Reaction to FDA’s Decision to Begin Rationing the late-stage cancer drug Avastin for breast cancer patients

◼ The Wall St. Journal says: Yesterday the Food and Drug Administration moved to revoke its regulatory approval of Avastin for metastatic breast cancer. Withdrawing a cancer treatment is almost never done, and though the decision was expected, that does not make it any less reprehensible. - a compilation of reactions at Big Government